ChromaDex Corporation reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 21.2 million compared to USD 21 million a year ago. Net income was USD 0.114 million compared to net loss of USD 1.42 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.44 USD | +1.47% | -6.78% | +140.56% |
Apr. 23 | Chromadex Announces Inaugural Major Grocery Debut of Tru Niagen® At Sprouts Farmers Market | CI |
Apr. 09 | Roth MKM Raises Price Target on ChromaDex to $6 From $4.25, Keeps Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+140.56% | 260M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CDXC Stock
- News ChromaDex Corporation
- ChromaDex Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023